Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate

Since reduced antithrombin III (AT III) activity are associated with increased risk of thromboembolism, we have determined it in 39 patients with prostatic carcinoma. Pre-treatment levels were determined in 24 patients, 6 additional patients with prostatic carcinoma on estrogen treatment and 9 patie...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 35(1989), 5 vom: 15. Mai, Seite 807-13
Auteur principal: Hayashi, T (Auteur)
Autres auteurs: Takenawa, J, Ryoji, O, Hiura, M, Taki, Y, Kiriyama, T
Format: Article
Langue:Japanese
Publié: 1989
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Comparative Study English Abstract Journal Article Estrogens Chlormadinone Acetate 0SY050L61N Ethinyl Estradiol 423D2T571U Diethylstilbestrol 731DCA35BT plus... Antithrombin III 9000-94-6